These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29775948)

  • 1. Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Rahimifard M; Baeeri M; Doostmohammadi M; Firoozpour L; Bukhari SNA; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
    Bioorg Chem; 2018 Sep; 79():223-234. PubMed ID: 29775948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
    Jalili-Baleh L; Forootanfar H; Küçükkılınç TT; Nadri H; Abdolahi Z; Ameri A; Jafari M; Ayazgok B; Baeeri M; Rahimifard M; Abbas Bukhari SN; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2018 May; 152():600-614. PubMed ID: 29763808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
    Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
    Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
    Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi-Target-Directed Ligands against Alzheimer's Disease.
    Abdshahzadeh H; Golshani M; Nadri H; Saberi Kia I; Abdolahi Z; Forootanfar H; Ameri A; Tüylü Küçükkılınç T; Ayazgok B; Jalili-Baleh L; Sadat Ebrahimi SE; Moghimi S; Haririan I; Khoobi M; Foroumadi A
    Chem Biodivers; 2019 May; 16(5):e1800436. PubMed ID: 30957958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation.
    Pagoni A; Marinelli L; Di Stefano A; Ciulla M; Turkez H; Mardinoglu A; Vassiliou S; Cacciatore I
    Eur J Med Chem; 2020 Jan; 186():111880. PubMed ID: 31753513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease.
    Nesi G; Chen Q; Sestito S; Digiacomo M; Yang X; Wang S; Pi R; Rapposelli S
    Eur J Med Chem; 2017 Dec; 141():232-239. PubMed ID: 29031070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease.
    Kaur A; Mann S; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
    Bioorg Chem; 2019 Jun; 87():572-584. PubMed ID: 30928879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Qiang X; Li Y; Yuan W; Liu Q; Shi Y; Ang W; Luo Y; Tan Z; Deng Y
    Eur J Med Chem; 2015 Apr; 94():348-66. PubMed ID: 25778991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and structure-activity relationship studies of hederacolchiside E and its derivatives as potential anti-Alzheimer agents.
    Li HN; Liu Y; Zhang ZP; Wang ZP; Hao JZ; Li FR; Fan ZF; Zou LB; Cheng MS
    Eur J Med Chem; 2018 Jan; 143():376-389. PubMed ID: 29202401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
    Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
    Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Zhao Y; Ye F; Xu J; Liao Q; Chen L; Zhang W; Sun H; Liu W; Feng F; Qu W
    Bioorg Med Chem; 2018 Jul; 26(13):3812-3824. PubMed ID: 29960728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.